Skip to main content
Jennifer Brown, MD, Oncology, San Mateo, CA

Jennifer A Brown MD


Physician

Join to View Full Profile
  • 218 De Anza BlvdSan Mateo, CA 94402

  • Phone+1 650-341-9131

  • Fax+1 650-341-9135

Dr. Brown is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1999 - 2002
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1999

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2025 - 2028
  • TX State Medical License
    TX State Medical License 2025 - 2028
  • MO State Medical License
    MO State Medical License 2026 - 2027
  • WI State Medical License
    WI State Medical License 2025 - 2027
  • TN State Medical License
    TN State Medical License 2025 - 2027
  • OR State Medical License
    OR State Medical License 2024 - 2027
  • NV State Medical License
    NV State Medical License 2025 - 2027
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2012, 2014-2015
  • CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • Verastem Oncology Reports on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma Opportunity, Landscape and Advancements in Pre-Commercial Initiatives at Analyst and Investor Day
    Verastem Oncology Reports on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma Opportunity, Landscape and Advancements in Pre-Commercial Initiatives at Analyst and Investor DayMay 3rd, 2018
  • Efforts Continue to Optimize Ibrutinib in CLL
    Efforts Continue to Optimize Ibrutinib in CLLJune 2nd, 2016
  • Newer Agents, Combinations Being Studied for Targeted Therapies in CLL
    Newer Agents, Combinations Being Studied for Targeted Therapies in CLLMarch 20th, 2016

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: